There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease #osteoarthritis NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs
Currently, only injectable or oral prescription medications can deliver proven GLP-1 effects for weight loss
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)
Yes, Ozempic is available on the NHS
The LactMed database states that tirzepatide use is not a reason to discontinue breastfeeding
GLP-1 analogs have been developed for the treatment of type II diabetes mellitus